Reduced expression of TSPAN14 leads to enhanced expression of MMP-2 and MMP-9 (matrix-degrading enzymes), resulting in the enhanced ability of cancer cells to degrade the matrix (Jovanović et al. 2022). The gene discussed is MMP2; the disease is cancer.